Trastuzumab and HER2 Targeted Cancer Treatment
/ Jan Trøst Jørgensen
Insights into Tumor Microenvironment Antigens and Immunomodulation
/ Mads Hald Andersen
DESTINY-Breast03 Study: Trastuzumab Deruxtecan versus Trastuzumab Emtansine
/ Giuseppe Curigliano